A detailed history of Raleigh Capital Management Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 92 shares of NVO stock, worth $9,441. This represents 0.0% of its overall portfolio holdings.

Number of Shares
92
Previous 91 1.1%
Holding current value
$9,441
Previous $12,000 16.67%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$119.07 - $145.42 $119 - $145
1 Added 1.1%
92 $10,000
Q3 2023

Dec 06, 2023

BUY
$90.94 - $199.54 $4,183 - $9,178
46 Added 102.22%
91 $8,000
Q1 2023

May 22, 2023

BUY
$132.34 - $159.14 $5,955 - $7,161
45 New
45 $7,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Raleigh Capital Management Inc. Portfolio

Follow Raleigh Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raleigh Capital Management Inc. with notifications on news.